SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001683168-23-008964
Filing Date
2023-12-19
Accepted
2023-12-19 16:52:55
Documents
17

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT phio_s1.htm   iXBRL S-1 276218
2 HOGAN LOVELLS OPINION phio_ex0501.htm EX-5.1 9257
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM phio_ex2301.htm EX-23.1 2338
4 CALCULATION OF FILING FEE TABLES phio_ex107.htm EX-FILING FEES 39194
5 GRAPHIC phiologo.jpg GRAPHIC 8850
6 GRAPHIC hoganlovellslogo.jpg GRAPHIC 8406
  Complete submission text file 0001683168-23-008964.txt   577921

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE phio-20231219.xsd EX-101.SCH 3021
8 XBRL LABEL FILE phio-20231219_lab.xml EX-101.LAB 34767
9 XBRL PRESENTATION FILE phio-20231219_pre.xml EX-101.PRE 22721
11 EXTRACTED XBRL INSTANCE DOCUMENT phio_s1_htm.xml XML 2743
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-276146 | Film No.: 231498126
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)